Table 3

Number of enhancing lesions on baseline MRI and newly active lesions on six months of follow up scans in patients with SPMS

Patient No		Baseline scan		Months of follow up		AII		AIII
Patient No		Baseline scan		1	2	AII		AIII		3	4	5	6
1	0	0	1	1	0	0	0	33	2
2	0	0	0	0	0	0	1	17	1
3	1	0	1	5	3	10	12	83	31
4	0	0	0	0	0	0	0	0	0
5	0	0	0	0	0	0	0	0	0
6	0	0	0	0	0	0	0	0	0
7	0	0	1	1	0	0	0	33	2
8	0	3	1	2	1	2	1	100	10
9	1	0	1	0	0	0	0	17	1
10	0	0	0	0	0	1	3	33	4
11	0	0	0	0	0	0	0	0	0
12	0	0	1	0	2	4	2	67	9
13	0	0	0	1	2	4	2	67	9
14	16	13	13	5	1	0	7	83	39
15	3	2	4	11	3	9	2	100	31
16	6	2	3	6	3	4	1	100	19
17	5	6	5	2	3	2	2	100	20
18	10	15	9	5	7	9	21	100	66
19	0	0	0	3	0	2	2	50	7
20	1	0	0	0	0	0	1	17	1
21	0	3	36	4	17	10	15	100	85
22	1	0	4	0	0	1	0	33	5
23	0	0	0	0	1	1	0	33	2
24	0	0	0	0	0	0	0	0	0
25	1	0	0	0	0	0	0	0	0
26	0	1	0	0	0	0	0	17	1
27	0	0	0	0	0	0	1	17	1
28	0	1	0	0	3	0	1	50	5

AII= the percentage of scans (per patient) on which newly active lesions were seen.
AIII= the total number of active lesions seen during the study period.